Can Sun’s Novel Partnered Topical Drug Alter Acne Options?

Sun-Cassiopea’s novel mechanism of action acne drug sees a “fair degree” of early physician interest in the US, with some analysts expecting the topical androgen receptor inhibitor to emerge as a key addition to the Indian’s firm’s specialty portfolio.